Teva Pharmaceutical Industries (TEVA) Other Gross PP&E Adjustments: 2009-2025
Historic Other Gross PP&E Adjustments for Teva Pharmaceutical Industries (TEVA) over the last 8 years, with Sep 2025 value amounting to -$342.0 million.
- Teva Pharmaceutical Industries' Other Gross PP&E Adjustments rose 6.04% to -$342.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 billion, marking a year-over-year decrease of 3.17%. This contributed to the annual value of $3.4 billion for FY2024, which is 2.84% down from last year.
- According to the latest figures from Q3 2025, Teva Pharmaceutical Industries' Other Gross PP&E Adjustments is -$342.0 million, which was up 4.47% from -$358.0 million recorded in Q2 2025.
- Teva Pharmaceutical Industries' 5-year Other Gross PP&E Adjustments high stood at $3.4 billion for Q4 2023, and its period low was -$531.0 million during Q2 2021.
- In the last 3 years, Teva Pharmaceutical Industries' Other Gross PP&E Adjustments had a median value of -$363.0 million in 2025 and averaged $309.7 million.
- As far as peak fluctuations go, Teva Pharmaceutical Industries' Other Gross PP&E Adjustments tumbled by 585.14% in 2021, and later increased by 16.95% in 2022.
- Quarterly analysis of 5 years shows Teva Pharmaceutical Industries' Other Gross PP&E Adjustments stood at $2.8 billion in 2021, then grew by 10.82% to $3.1 billion in 2022, then grew by 11.15% to $3.4 billion in 2023, then dropped by 2.84% to $3.4 billion in 2024, then climbed by 6.04% to -$342.0 million in 2025.
- Its Other Gross PP&E Adjustments was -$342.0 million in Q3 2025, compared to -$358.0 million in Q2 2025 and -$363.0 million in Q1 2025.